Inventor · disambiguated record
Ye Huang
Also filed as: HUANG YE
7 granted patents·19 pending applications·40 citations·filing 2004–2025
83Inventor score
Top patents by PatentIndex Score
26 records- 0188US10016393B2Stabilized pharmaceutical dosage forms comprising atrasentanABBVIE INC·Filed 2016·Granted Jul 10, 2018·11 cites·11 claims
- 0288US9364458B2Stabilized pharmaceutical dosage forms comprising atrasentanABBVIE INC·Filed 2014·Granted Jun 14, 2016·16 cites·36 claims
- 0386US9446059B2Carbidopa and L-dopa prodrugs and methods of useABBVIE INC·Filed 2015·Granted Sep 20, 2016·5 cites·24 claims
- 0485US11091507B2Methods of treating Parkinson's diseaseABBVIE INC·Filed 2020·Granted Aug 17, 2021·1 cites·17 claims
- 0584US10174061B2Carbidopa and L-dopa prodrugs and methods of useABBVIE INC·Filed 2017·Granted Jan 8, 2019·3 cites·4 claims
- 0680US2023106081A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2022·Application pending·0 cites
- 0777US10117843B2Levodopa and carbidopa intestinal gel and methods of useABBVIE INC·Filed 2016·Granted Nov 6, 2018·4 cites·11 claims
- 0875US2022153765A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2021·Application pending·0 cites
- 0969US2024316040A1Extended release upadacitinib formulationsABBVIE INC·Filed 2021·Application pending·0 cites
- 1069US2023129413A1Levodopa and Carbidopa Intestinal Gel and Methods of UseABBVIE INC·Filed 2022·Application pending·0 cites
- 1164US2025161302A1Extended release upadacitinib formulationsABBVIE INC·Filed 2025·Application pending·0 cites
- 1262US2024024338A1Carbidopa and l-dopa prodrugs and methods of useABBVIE INC·Filed 2023·Application pending·0 cites
- 1361US2014044782A1Controlled release formulations of opioid and nonopioid analgesicsALZA CORP·Filed 2013·Application pending·0 cites
- 1460US2013209525A1Controlled release formulations of opioid and nonopioid analgesicsALZA CORP·Filed 2013·Application pending·0 cites
- 1559US2021059968A1Levodopa and carbidopa intestinal gel and methods of useABBVIE INC·Filed 2020·Application pending·0 cites
- 1658US2016362431A1Carbidopa And L-Dopa Prodrugs And Methods Of UseABBVIE INC·Filed 2016·Application pending·0 cites
- 1757US2006251721A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2006·Application pending·0 cites
- 1856US2005158382A1Controlled release formulations of opioid and nonopioid analgesicsFiled 2004·Application pending·0 cites
- 1956US2012251590A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2012·Application pending·0 cites
- 2056US2021046029A1Levodopa and carbidopa intestinal gel and methods of useABBVIE INC·Filed 2020·Application pending·0 cites
- 2155US2012165358A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2011·Application pending·0 cites
- 2251US2010221293A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2010·Application pending·0 cites
- 2349US2019142777A1Levodopoa and Carbidopa Intestinal Gel and Methods of UseABBVIE INC·Filed 2018·Application pending·0 cites
- 2449US2018021280A1Levodopa and Carbidopa Intestinal Gel and Methods of UseABBVIE INC·Filed 2017·Application pending·0 cites
- 2543US2025177332A1Pharmaceutical dosage form of lacosamideSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 2642US12478587B1Formulation for lacosamideSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2025·Granted Nov 25, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ye Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →